Abstract
Introduction

In the past, most studies of the regulation of gene expression have focused mainly upon transcriptional activity. Over the last few years, microRNA (miRNA)-mediated post-transcriptional regulation of protein-coding genes has emerged as a promising area of research. This regulation provides the cell with a more precise, immediate and energy-efficient mechanism for controlling the expression of proteins. This occurs since it can mediate rapid
changes in protein synthesis without the need for transcriptional activation and subsequent mRNA processing steps [1] . The first miRNA was discovered in 1993 by Lee et al . [2] [6] .
In mammalian cells, miRNAs are initially transcribed in the nucleus as long primary miRNA (pri-miRNA) transcripts that are subsequently processed to produce hairpin-like miRNA precursors (premiRNAs) that range in length from 60 to 110 nucleotides (nt). The pre-miRNAs are transported to the cytoplasm where they are further processed into ~22-nt duplexes of mature miRNA strand and
an miRNA passenger strand, with 2-nt overhangs at the 3Ј termini [7] . The mature miRNA strand is incorporated into the ribonucleoprotein complex RISC (RNA-induced silencing complex), while the passenger strand is degraded. The mature miRNA binds to its target mRNA(s) by complete or partial complementarity of the 5Ј-end nucleotides 2-8 or 2-7 (seed sequences) with a binding site in the 3Ј-UTR of the target transcripts [8] [9] [10] [11] . This subsequently results in either direct cleavage of the targeted mRNAs by nucleases within the RISC or inhibition of translation [12] . The characteristically short seed sequence permits a single miRNA to act on multiple target sites. Bioinformatic analyses have predicted that each miRNA recognizes on average about 100-200 different mRNA targets [5, 13] and thus miRNAs can mediate the regulation of a considerable number of protein-coding genes [14] . Additionally, the 3Ј-UTR of a given mRNA may contain binding sites for various miRNAs. As a result, miRNAs are involved in almost all cellular processes in mammals, including cell proliferation, differentiation, stress response, apoptosis, immunity and transcriptional regulation [5] .
There is now abundant evidence that aberrant expression of miRNAs occurs in diverse types of human cancer and in different stages of disease progression [15, 16] . Moreover, several miRNAs have recently been found to promote cell survival and tumour growth [17] [18] [19] . Therefore, miRNAs may play a critical role in the pathogenesis of human cancer. Studies have shown that some miRNAs can be overexpressed or down-regulated in cancer cells [20] 
Aberrant expression of miRNAs in prostate cancer
CaP is the most frequently diagnosed malignant tumour and the second leading cause of cancer deaths in American men [26] . Retrospective studies suggest that by age 80, more than half of all American men have some cancerous cells in their prostate [27] [34] . However, the lack of comparability and low accuracy of the derived data have been a major limitation of miRNA microarray studies [35] [20, 37] [9, 21, 25] 
Biological function of prostate cancer-related miRNAs
The initiation and progression of CaP is a complex biological process involving multiple biochemical and genetic factors. Like other human cancer types, the inactivation of tumour suppressor genes and the activation of oncogenes may be major contributors to this disease. Since miRNAs function as oncogenes (onco-miRNAs) or tumour suppressors (ts-miRNAs)
miR-20a
The miR-17-92 cluster resides on chromosome 13 [38] . Since miR-20a from this cluster is overexpressed in clinical CaP samples [20] , Sylvestre et al. [39] 
and comprises seven miRNAs (miR-17-5p, miR-17-3p, miR-18a, miR-19a, miR-20a, miR-19b-1 and miR-92-1). A previous study demonstrated that this miRNA cluster could modulate tumour formation and functions as oncogenes
miR-125b
Up-regulation of miR-125b was observed in PC3 [30] , in LNCaP [33, 37] , LNCaP AI sublines [33, 37] and in a subset of clinical CaP samples [33, 36] . In a previous study, miR-125b was found to be critical for the proliferation of PC3 cells [30] 
miR-146a
As discussed above, Lin et al. [32] 
miR-221/222
In a recent study, Galardi et al. [41] [29, 33] [9] . The While various methods have been described for discovering miRNA-targeted mRNAs [43] [44] [45] [46] , there is no clear agreement as to which procedure should be utilized to determine that a given mRNA is a target of a specific miRNA [43] . Of [47] . The accurate selection of putative targets for experimental validation is a challenge. Iorio et al. [48] and Kuhn et al. [43] deemed that if a target is predicted using at least two of the three different algorithms, it should be considered as a good candidate for experimental validation. This rule has been used by several groups for identification of miRNA targets [36, 48, 49] (Table 2) . They are E2F1 [39] , Bak1 [33] , SLC45A3 (solute carrier family 45, member 3) [40] , ROCK1 [32] and p27
. Although the function of the miRNA in CaP remains to be defined, we recently observed that the miRNA is significantly up-regulated in LNCaP cells exposed to interleukin-6 (IL-6) compared to the LNCaP control. Since IL-6 plays an important role in androgen-independent growth of CaP cells [42], our finding suggests that let-7c may be related to IL-6-induced CaP progression. In summary, only a few CaP-related miRNAs have been characterized for their functional significance. These miRNAs may contribute to the pathogenesis of CaP through oncogenic activities or tumour suppressive functions, respectively. That being said, further investigations are warranted to identify CaP-related miRNAs and to better define the breadth and mechanisms of their biological activities. This will likely provide novel insights into the molecular alterations associated with this disease and potential opportunities for therapeutic interventions of CaP.
Identification of targets of prostate cancer-related miRNAs miRNAs are powerful repressors of gene expression, and their impact on the growth of CaP cells depends on the functions of downstream targets they suppress. For example, accumulation of an onco-miRNA that targets the mRNAs of tumour suppressors would result in reduction of the tumour suppressors. In contrast, decreased expression of a ts-miRNA that targets the mRNAs of proto-oncogenes could lead to excessive amounts of the oncogenic proteins
Kip1 [41] [54, 55] . This molecule is an important determinant of motility and invasiveness of CaP cells [40] . ROCK1 is a Rho-activated protein kinase that is highly involved in AI growth and metastasis of PC3 cells [56] . Active ROCK1 increases phosphorylation of myosin light chain and subsequent contraction of actin-myosin complex, which might enhance cancer migration and metastasis [57] . Active ROCK1 can also promote the activation of PI3K [56] [70] . In recent studies, repression of CaP-related oncogenic miRNAs (miR-20a, miR-125b and miR221/222) using specific anti-miRNAs resulted in a significant increase in cell death [33, 39, 41] 
Regulation of miRNAs in prostate cancer
Limited information is available regarding the regulation of the expression of miRNAs. Studies have shown that factors that affect the expression of protein-encoding genes can disrupt the regulation of miRNAs in cancer cells
